What is Kopin's grant — revenue?

Kopin (KOPN) reported grant — revenue of $2.6M in Q2 2026.

How has Kopin's grant — revenue changed year-over-year?

Kopin's grant — revenue increased by 1111.4% year-over-year, from $214.5K to $2.6M.

What does grant — revenue mean?

This metric represents the total revenue recognized from government or research grants associated with specific contractual obligations, excluding any assessed taxes. It reflects the financial support received for research and development activities or specialized project-based initiatives within the company's portfolio. This figure is critical for assessing the company's ability to secure non-dilutive funding and its success in executing government-sponsored technological development programs.

Kopin (KOPN) Grant — Revenue — Quarterly & Annual

Screener

Other product segments

ASC Six Zero Six Revenues

$9.86M—

Net Product Revenue

$7.64M—

Defense

$7.31M+17.5%

Non ASC Six Zero Six Revenues

$2.87M—

Research And Development

$2.17M+139%

Medical

$309.34K+45.0%

Collaboration

$271.48K—

Other Product

$78K-75.6%

License And Royalties

$56K+15.4%

Consumer And Other Product

$50.16K—

Industrial

$20.4K-98.0%

Similar metrics at other companies

CRSPGrant — Revenue

$458K-47.1%

CLDXGrant — Revenue

$15K-97.9%

ORGOGrant — Revenue

$950K+320%

BLNKGrant And Fee Rebate — Revenue

$33K+3.1%

APEIInstructional services, net of grants and scholarships — Revenue

$156.26M+4.3%

ORCLCloud Revenues — Revenue

$9.91B+47.1%

Other financials

Income statement

See full

Revenue$12.7M+50.6%

Operating income-$3.5M+35.8%

Net income$830.9K+116%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$24.9M+2.1%

Total debt$1.2M-47.2%

Total equity$69.2M+331%

Total assets$106.3M+73.7%

Cash flow

See full

Operating cash flow-$4.3M-4.2%

CapEx$3.8M+420%

Free cash flow-$8.1M-66.4%

Valuation

See full

Market cap$791.24M+170%

Enterprise value$767.52M+184%

P/E99.3×—

P/S18.1×+11.9×

Profitability

See full

Gross margin46.7%—

Operating margin-22.9%-4.6pp

Net margin18.3%+11.3pp

FCF margin-42.2%+7.0pp

Returns & leverage

See full

Return on equity18.7%—

Debt / equity0×-0.1×

Current ratio2.2×+0.9×

Where this comes from

Reported directly by Kopin in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Kopin’s 10-Q, filed August 11, 2026.

Filed: Aug 11, 2026, 5:23 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001493152-26-037194

Line item	Three Months Ended June 27, 2026	Three Months Ended June 28, 2025	Six Months Ended June 27, 2026	Six Months Ended June 28, 2025
Grant income	2,598,546	—	6,040,241	—
Collaboration arrangement income	271,478	—	601,089	—
License and other revenues	55,998	48,540	120,926	120,480
Total revenues	12,734,434	8,454,883	23,285,804	18,993,375
Expenses:
Cost of product revenues	6,587,365	7,071,517	12,196,620	14,700,984
Research and development – Funded	3,326,842	463,978	7,133,074	1,102,697
Research and development – Internal	1,197,238	1,481,458	2,302,573	2,958,660

Document

FAQ

What is Kopin's grant — revenue?: Kopin (KOPN) reported grant — revenue of $2.6M in Q2 2026.
How has Kopin's grant — revenue changed year-over-year?: Kopin's grant — revenue increased by 1111.4% year-over-year, from $214.5K to $2.6M.
What does grant — revenue mean?: This metric represents the total revenue recognized from government or research grants associated with specific contractual obligations, excluding any assessed taxes. It reflects the financial support received for research and development activities or specialized project-based initiatives within the company's portfolio. This figure is critical for assessing the company's ability to secure non-dilutive funding and its success in executing government-sponsored technological development programs.